Skip to content
Toggle navigation
About Us
Overview
Leadership Team
Board of Directors
Science & Platform
What is Immune Tolerance?
Our Approach
Pipeline
Overview
SynCeD
ACeD-it | Celiac Disease
ACeD | Celiac Disease
MoveS-it | Multiple Sclerosis
Investors & Media
Overview
Press Releases
Publications
In the News
Careers
Contact
About Us
Overview
Leadership Team
Board of Directors
Science & Platform
What is Immune Tolerance?
Our Approach
Pipeline
Overview
SynCeD
ACeD-it | Celiac Disease
ACeD | Celiac Disease
MoveS-it | Multiple Sclerosis
Investors & Media
Overview
Press Releases
Publications
In the News
Careers
Contact
Terms of Use
Privacy: US
Privacy: EU/UK
Site Credits
Investors & Media
Press Releases
Press Releases
Press Releases
2015
2024
2023
2022
2021
2020
2019
2018
2017
2015
2014
2012
June 02, 2015
Astellas and Anokion to Collaborate on Immune Tolerance Therapeutics – Kanyos Bio established to develop products for Celiac Disease and Type 1 Diabetes
Read More